Transsphenoidal pituitary surgery

What is transsphenoidal pituitary surgery and how is it performed?

Transsphenoidal pituitary surgery is a minimally invasive surgical procedure used to remove tumours from the pituitary gland, a small endocrine organ located at the base of the brain directly beneath the optic nerves. Rather than opening the skull through a traditional craniotomy, the surgical team reaches the skull base by navigating through the nostrils, the nasal cavity, and the air-filled sphenoid sinus. The bone covering the pituitary fossa (the sella turcica) is opened to expose the tumour for precise micro-resection. Surgical centres offering neurosurgery treatments in Turkey routinely carry out this operation using high-definition endoscopes or surgical operating microscopes, often in collaboration with ear, nose, and throat (ENT) skull base specialists.

Most pituitary tumours are non-cancerous adenomas. They cause clinical problems in two primary ways: by growing large enough to compress adjacent structures such as the optic chiasm (mass effect causing peripheral vision loss), or by secreting excess hormones such as prolactin, growth hormone (causing acromegaly), or adrenocorticotropic hormone (causing Cushing's disease). This guide explains what the procedure involves, what published medical evidence demonstrates regarding hormonal control and tumour clearance, how much transsphenoidal pituitary surgery cost differs between countries, the recovery process, and how to evaluate a hospital.

Get my free quote

How does the transsphenoidal approach access the pituitary gland?

The anatomy of the skull base makes the sphenoid sinus a natural anatomical corridor to the pituitary gland. In what is transsphenoidal pituitary surgery, the patient is placed under general anaesthesia with the head secured in a rigid frame. Using optical navigation systems that link pre-operative magnetic resonance imaging (MRI) scans with real-time surgical instruments, the surgeon introduces an endoscope or speculum into one or both nostrils.

The surgeon gently moves the nasal turbinates aside and opens the anterior wall of the sphenoid sinus (sphenoidotomy). Once inside the sinus cavity, the bony floor of the sella turcica is visualised directly below the optic chiasm and flanked laterally by the internal carotid arteries. The surgeon removes a small window of bone and makes a tiny incision in the dura mater, revealing the pituitary capsule. Because adenomas are typically softer and distinct in colour and texture from the normal anterior pituitary gland, the neurosurgeon carefully separates the tumour from healthy glandular tissue, preserving endocrine function whenever possible. After tumour removal, the surgical corridor is inspected for bleeding, and the skull base floor is reconstructed to ensure a watertight seal.

Does transsphenoidal pituitary surgery work for adenomas and hormone excess?

Clinical consensus from global neurosurgical bodies, including the Pituitary Society and the European Association of Neurosurgical Societies, confirms that transsphenoidal resection is the established surgical intervention for symptomatic pituitary adenomas. When an adenoma compresses the optic chiasm, surgical decompression relieves visual field deficits in approximately 75% to 85% of patients, particularly when treated before permanent optic nerve atrophy occurs.

For functioning (hormone-secreting) tumours, does transsphenoidal pituitary surgery work depends largely on tumour size, invasiveness, and initial hormone levels. In microadenomas (tumours under 10 millimetres confined entirely to the sella), surgical remission rates for Cushing's disease and acromegaly reach 70% to 90% in experienced centres. For macroadenomas (tumours larger than 10 millimetres) that invade the cavernous sinuses or wrap around carotid vessels, complete biochemical cure is harder to achieve through surgery alone. In these complex cases, subtotal resection debulks the tumour mass, relieving pressure on surrounding neural structures, while residual microscopic remnants are managed with targeted radiotherapy (such as stereotactic radiosurgery) or ongoing medical therapy. A reputable clinic will never promise an assured biochemical cure without reviewing high-resolution MRI scans and baseline endocrinology profiles.

Transsphenoidal pituitary surgery cost in Turkey compared with the UK, US and Germany

The figures below provide approximate cost ranges for transsphenoidal pituitary surgery in Turkey compared with private healthcare providers in the United Kingdom, the United States, and Germany. These figures reflect complete hospital stays, operative fees, and routine specialist care, rather than individual clinic quotes. Every patient receives a tailored quotation following multidisciplinary evaluation of their imaging.

Several clinical variables affect the final transsphenoidal pituitary surgery price. These include the size and invasiveness of the lesion, whether the procedure requires a two-surgeon team (rhinologist and neurosurgeon), the complexity of skull base reconstruction (such as vascularised nasoseptal flaps), the length of intensive care unit (ICU) monitoring, and the extent of post-operative hormone replacement testing. In Turkey, medical travel packages generally cover pre-admission diagnostics, neuro-navigation usage, the operation and anaesthetist fees, one night in neuro-intensive care, three to four nights on a surgical ward, routine pathology, follow-up consultations, and airport transfers.

Get my free quote

Endoscopic endonasal resection, microscopic surgery or open craniotomy?

Modern skull base surgery offers different operative techniques depending on tumour architecture. The two primary transnasal methods are endoscopic surgery and microscopic surgery. In certain massive or asymmetric lesions, an open craniotomy may still be required. Where anterior skull base tumours extend beyond the sella, teams may also deploy wider transnasal resection of tumor approaches.

Endoscopic surgery uses rigid endoscopes with varying angles (0°, 30°, and 45°), allowing the surgical team to look around anatomical corners and directly inspect the junction between the tumour and the normal pituitary tissue. Microscopic surgery relies on a surgical microscope and an intranasal speculum, offering stereoscopic depth perception in a straight line. Many specialised neurosurgical departments in Turkey employ both technologies, selecting the approach that matches the individual tumour anatomy.

Who is a candidate for transnasal adenoma resection?

Surgical intervention through the transsphenoidal route is primarily recommended for patients with documented pituitary lesions that cannot be managed solely through medication or observation. Suitable candidates generally include:

• Patients with non-functioning pituitary macroadenomas causing optic chiasm compression, visual field cuts, or progressive visual decline.
• Individuals with hormone-producing tumours, including ACTH-secreting adenomas (Cushing's disease), growth-hormone-secreting adenomas (acromegaly), or TSH-secreting adenomas that require surgical clearance to stop systemic endocrine damage.
• Patients with prolactinomas that have proven resistant to or intolerant of dopamine agonist medications such as cabergoline, or where rapid visual decompression is needed.
• Individuals with pituitary apoplexy (acute haemorrhage or infarction into a pre-existing adenoma) presenting with severe headache and sudden visual failure, requiring urgent decompression.

You may not be an appropriate candidate if you have small, asymptomatic non-functioning microadenomas that are discovered incidentally and show no growth over time (incidentalomas), where periodic MRI surveillance is standard practice. Patients with active, untreated systemic infections, severe unmanaged cardiovascular disease, or uncorrectable bleeding disorders are also unsuitable until stabilized. For complex anatomical variants, your team might evaluate broader transnasal skull base techniques before deciding on an operative plan.

Step by step: what happens during the operation?

Transsphenoidal pituitary surgery follows a rigorous, multidisciplinary protocol that typically lasts between two and four hours:

• Pre-operative preparation and anaesthesia: You are placed under general anaesthesia. Neuronavigation references are registered using your pre-surgical CT and MRI scans. Decongestant pledgets are placed in the nasal passages to minimise mucosal bleeding.
• Nasal corridor creation: An ENT surgeon or neurosurgeon uses an endoscope to access the posterior nasal cavity. A gentle lateralisation of the middle turbinates creates a clear pathway to the sphenoid ostium. In large tumours, a vascularised nasoseptal mucosal flap is prepared to seal the skull base later.
• Sphenoidotomy and sella exposure: The anterior sphenoid sinus wall is opened. The anatomical landmarks—including the sella floor, optic canals, and carotid prominences—are identified under high-definition visualisation and verified with stereotactic navigation.
• Dura incision and tumour resection: The thin bone of the sella is carefully removed. The underlying dura is incised. The surgeon uses specialized ring curettes and micro-suction instruments to debulk and excise the adenoma, taking care to preserve the compressed normal pituitary gland and avoid injury to the arachnoid membrane above.
• Reconstruction and closure: Once the tumour cavity is cleared and haemostasis is achieved, the skull base floor is rebuilt. The surgeon may use synthetic collagen sponges, autologous abdominal fat grafts, or the prepared nasoseptal flap, secured with surgical fibrin sealant, to prevent cerebrospinal fluid leaks. Nasal splints or dissolving dressings may be placed inside the nostrils.

Transsphenoidal pituitary surgery recovery timeline and hospital stay

Your overseas medical journey for transsphenoidal pituitary surgery in Turkey usually requires an overall stay of seven to ten days. Hospital admission takes place the day before surgery for pre-operative baseline endocrine profiling, anaesthetic checks, and neuronavigation scans. Following the operation, you spend the first night in an intensive care or neuro-intermediate unit for close neurological and fluid-balance observation.

On the ward (days two to four), doctors monitor your urine output and blood electrolyte levels hourly to detect transient diabetes insipidus, a temporary drop in anti-diuretic hormone secretion common after pituitary manipulation. Most patients begin walking with assistance within 24 to 48 hours. Nasal congestion and a mild frontal headache are normal; your team provides saline nasal rinses and oral pain relief. You are discharged to your hotel around day four or five, returning for follow-up nasal endoscopy, suture removal (if an abdominal fat graft site was used), and repeat blood tests before your flight home. Desk-based work can usually resume four to six weeks post-surgery, while heavy lifting, vigorous exercise, and nose blowing must be strictly avoided for six to eight weeks to protect the healing skull base.

Get my free quote

Before and after surgery: realistic visual and hormonal outcomes

Unlike aesthetic operations, results from transsphenoidal adenomectomy are measured through objective diagnostic metrics rather than cosmetic appearance. Before surgery, patients undergo formal automated perimetry (visual field testing) and detailed serum hormone assays. In cases where an adenoma compressed the chiasm, patients frequently report marked subjective brightening of their visual field within days of surgery, with formal visual perimetry demonstrating gradual recovery over the following three to six months.

For hormone-secreting tumours, post-operative success is confirmed by biochemical testing. In Cushing's disease, morning cortisol levels are checked in the immediate post-operative window to verify remission. In acromegaly, oral glucose tolerance testing and IGF-1 measurements are repeated at three months. A post-operative baseline MRI scan is usually scheduled at three months to assess the extent of tumour resection. It is important to maintain realistic expectations: while transsphenoidal pituitary surgery recovery restores optic nerve decompression, longstanding visual deficits caused by chronic optic nerve atrophy may not completely reverse. In addition, some patients require temporary or permanent hormone replacement (hydrocortisone, levothyroxine, or desmopressin) if the normal pituitary gland was compromised before or during surgery.

Risks and potential complications of transsphenoidal hypophysectomy

While transsphenoidal access avoids the morbidity of a major craniotomy, it remains a delicate intracranial procedure. Professional bodies such as the Society of British Neurological Surgeons (SBNS) and the NHS highlight several documented transsphenoidal pituitary surgery risks:

• Cerebrospinal fluid (CSF) leak: If the thin arachnoid membrane separating the pituitary fossa from the brain's fluid spaces is breached, CSF can leak into the sphenoid sinus and nose. Mild leaks may be managed with lumbar drainage, but persistent leaks require surgical re-exploration and grafting.
• Diabetes insipidus (DI): Temporary disturbance of the posterior pituitary gland can lead to excessive urination and intense thirst. It occurs in 10% to 20% of patients and is managed with desmopressin (DDAVP); permanent DI is much rarer, occurring in approximately 1% to 2% of cases.
• Hypopituitarism: Damage to the normal gland tissue can cause low production of adrenal, thyroid, or sex hormones, requiring daily oral hormone supplementation.
• Nasal complications: Temporary sinus congestion, minor nosebleeds, reduced sense of smell, or crusting are common and generally resolve with regular saline irrigation over four to eight weeks.
• Meningitis: Infection introduced via the nasal cavity into the cerebrospinal fluid is a rare but serious risk, prevented with sterile surgical technique and prophylactic peri-operative antibiotics.
• Major vascular or neural injury: Carotid artery laceration or direct optic nerve injury occurs in less than 1% of operations in experienced skull base centres using neuronavigation.

Choosing a neurosurgical team, red flags and questions to ask

Pituitary surgery requires high surgical volume and specialised multidisciplinary coordination. When seeking neurosurgical care in Turkey, verify that your chosen hospital maintains a dedicated pituitary multidisciplinary team (MDT) featuring both a fellowship-trained skull base neurosurgeon and a dedicated neuro-endocrinologist. The facility must possess intra-operative neuronavigation, high-resolution endoscopes, an on-site neuro-intensive care unit, and 24-hour hormone assay laboratory capabilities.

Be alert to red flags: avoid any coordinator who offers a price quote without requesting recent high-resolution pituitary MRI scans (with contrast) and hormone panels, clinics that promise a 100% cure rate for invasive macroadenomas, or facilities lacking dedicated neuro-intensive care beds. You can explore how our medical coordination works and submit your diagnostics through our free quote portal to receive an itemised surgical evaluation. For broader neurosurgical information, consult our comprehensive guide on neurosurgical care options.

Questions to ask the surgical team

• How many transsphenoidal pituitary operations does the primary neurosurgeon perform each year?
• Will an ENT skull base surgeon co-operate with the neurosurgeon during the transnasal opening and closure?
• What type of intra-operative imaging and neuronavigation systems are used in the operating theatre?
• What is your centre's specific protocol for monitoring electrolyte balance and hormone levels immediately after surgery?
• What skull base reconstruction technique do you plan to use to prevent post-operative CSF leaks?
• What emergency provisions and aftercare support are in place if a delayed CSF leak or hormonal imbalance occurs after I return home?

Get my free quote

Hospitals with Neurosurgery in Turkey

Academic Hospital

Üsküdar, Istanbul

MoHHealth Tourism Licence+2

Get Free Quote

Lokman Hekim Istanbul Hospital

Pendik, Istanbul

JCIMoH+2

Get Free Quote

View all

Frequently asked questions